These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38053806)

  • 1. Update on changing Australian medicine names.
    Aust Prescr; 2023 Oct; 46(3):64. PubMed ID: 38053806
    [No Abstract]   [Full Text] [Related]  

  • 2. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
    Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
    MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough.
    Loizides U; Dominici M; Manderson T; Rizzi M; Robertson JS; de Sousa Guimarães Koch S; Timón M; Balocco R
    Cytotherapy; 2021 May; 23(5):357-366. PubMed ID: 33820700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
    Robertson JS; Loizides U; Adisa A; López de la Rica Manjavacas A; Rodilla V; Strnadova C; Weisser K; Balocco R
    Vaccine; 2022 Jan; 40(1):21-27. PubMed ID: 34844820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Identical INN "Imiglucerase" for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database.
    Tsang SF; Pandya S; Barakov K; Keutzer J; Lewis G; Ross L; Freisens S
    Drug Saf; 2022 Feb; 45(2):127-136. PubMed ID: 35020177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The INNs and outs of antibody nonproprietary names.
    Jones TD; Carter PJ; Plückthun A; Vásquez M; Holgate RG; Hötzel I; Popplewell AG; Parren PW; Enzelberger M; Rademaker HJ; Clark MR; Lowe DC; Dahiyat BI; Smith V; Lambert JM; Wu H; Reilly M; Haurum JS; Dübel S; Huston JS; Schirrmann T; Janssen RA; Steegmaier M; Gross JA; Bradbury AR; Burton DR; Dimitrov DS; Chester KA; Glennie MJ; Davies J; Walker A; Martin S; McCafferty J; Baker MP
    MAbs; 2016; 8(1):1-9. PubMed ID: 26716992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of the database on nonproprietary names of drugs].
    Hashiba S; Takenaka Y; Nakadate M
    Eisei Shikenjo Hokoku; 1989; (107):141-5. PubMed ID: 2636918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice.
    De Bruyne F; Ponçon A; Giai J; Dode X; Darmon D; Colin C; Gueyffier F; Letrilliart L
    Eur J Clin Pharmacol; 2019 Feb; 75(2):275-283. PubMed ID: 30368571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names.
    Bryan R; Aronson JK; ten Hacken P; Williams A; Jordan S
    PLoS One; 2015; 10(12):e0145431. PubMed ID: 26701761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Nonproprietary Names (INN) for pharmaceutical substances.
    Kopp-Kubel S
    Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How INNs are created. Making drug names safer by contributing to INN selection.
    Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more.
    Parren PWHI; Carter PJ; Plückthun A
    MAbs; 2017; 9(6):898-906. PubMed ID: 28621572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing Australian medicine names.
    Yik J
    Aust Prescr; 2017 Jun; 40(3):98-100. PubMed ID: 28798514
    [No Abstract]   [Full Text] [Related]  

  • 14. Think INN, prescribe INN, dispense INN: good professional practice.
    Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstacles to the universal application of INNs.
    Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia.
    Gavrilova A; Zolovs M; Latkovskis G; Urtāne I
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naming drug substances at the national level: mainly in the United Kingdom and the United States.
    Prescrire Int; 2012 Nov; 21(132):279. PubMed ID: 23210269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics That May Help in the Identification of Potentially Confusing Proprietary Drug Names.
    Shah MB; Merchant L; Chan IZ; Taylor K
    Ther Innov Regul Sci; 2017 Mar; 51(2):232-236. PubMed ID: 30231718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INN global nomenclature of biological medicines: A continuous challenge.
    Robertson JS; Chui WK; Genazzani AA; Malan SF; López de la Rica Manjavacas A; Mignot G; Thorpe R; Balocco R; Rizzi M
    Biologicals; 2019 Jul; 60():15-23. PubMed ID: 31130314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Common international names and trademarks in the pharmaceutical field].
    Pasotti V
    Boll Chim Farm; 1989 Apr; 128(4):121-4. PubMed ID: 2775524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.